V-Set and Transmembrane Domain Containing 2A (VSTM2A) Peptide
VSTM2A
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN937392
Quick Overview for V-Set and Transmembrane Domain Containing 2A (VSTM2A) Peptide (ABIN937392)
Target
VSTM2A
(V-Set and Transmembrane Domain Containing 2A (VSTM2A))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- DISHKLQISK VRKKDEGLYE CRVTDANYGE LQEHKAQAYL KVNANSHARR
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of VSTM2 A antibody,
Alternative Names: VSTM2A control peptide, VSTM2A antibody Blocking Peptide, Anti-VSTM2A Blocking Peptide, V-Set And Transmembrane Domain Containing 2A Blocking Peptide, MGC33530 Blocking Peptide, VSTM2 Blocking Peptide, VSTM2A, VSTMA-2, VSTMA 2, VSTMA-2 Blocking Peptide, VSTMA 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- VSTM2A (V-Set and Transmembrane Domain Containing 2A (VSTM2A))
-
Background
- This pseudogene is a member of the cytochrome P450 geneuperfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. It is possible that, in rare cases, a combination of two SNPs in this gene may result in an open reading frame encoding a functional enzyme which metabolizes codeine to morphine.
-
Molecular Weight
- 26 kDa
Target
-
You are here:
